Short Interest in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Expands By 32.8%

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Get Free Report) saw a significant increase in short interest in the month of September. As of September 15th, there was short interest totalling 1,820,000 shares, an increase of 32.8% from the August 31st total of 1,370,000 shares. Approximately 4.9% of the shares of the company are sold short. Based […]

Related Keywords

,Charles Schwab Investment Management Inc ,York Mellon Corp ,Corvus Pharmaceuticals Price Performance ,News Ratings For Corvus Pharmaceuticals Daily ,Virtu Financial ,Tower Research Capital ,Nasdaq ,Institutional Trading Of Corvus Pharmaceuticals ,Cantor Fitzgerald ,Corvus Pharmaceuticals ,Corvus Pharmaceuticals Inc ,Tucker Asset Management ,Get Free Report ,Asset Management ,Schwab Investment Management ,Research Capital ,New York Mellon Corp ,Corvus Pharmaceuticals Daily ,Nasdaq Crvs ,Ccrvs ,Medical ,Stocks ,Options ,Put ,Call ,